[Establishment of a simple fluorescent microscopy method for measurement of the CD4/CD8 ratio in BALF]

Y Konoike1, K Nishikawa, T Imai

  • 1Second Department of Internal Medicine, Nara Medical University, Japan.

Nihon Kyobu Shikkan Gakkai Zasshi
|March 1, 1990
PubMed

Insights

A new fluorescent microscopy method accurately measures the CD4/CD8 ratio in bronchoalveolar lavage fluid (BALF) for diagnosing diffuse pulmonary diseases. This simple technique aids in disease monitoring and diagnosis.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Microscopy Techniques

Background:

  • The CD4/CD8 ratio in bronchoalveolar lavage fluid (BALF) is a key indicator in diffuse pulmonary diseases.
  • Accurate measurement of BALF CD4/CD8 ratio is crucial for diagnosis and monitoring.

Purpose of the Study:

  • To establish a simple and reliable fluorescent microscopy method for measuring the CD4/CD8 ratio in BALF.
  • To evaluate the utility of this method in diagnosing and monitoring diffuse pulmonary diseases.

Main Methods:

  • Development of a fluorescent microscopy technique to quantify CD4+ and CD8+ T lymphocytes in BALF.
  • Correlation analysis of the novel method with flow cytometry for CD4/CD8 ratio determination.
  • Measurement of BALF CD4/CD8 ratios in patients with hypersensitive pneumonitis, sarcoidosis, collagen vascular disease, idiopathic interstitial pneumonitis, and measles pneumonia.

Main Results:

  • The fluorescent microscopy method showed strong correlation with flow cytometry for CD4/CD8 ratio in both peripheral blood and BALF.
  • BALF CD4/CD8 ratios varied significantly among different diffuse pulmonary diseases (e.g., low in HP and MP, high in SAR).
  • A decrease in BALF CD4/CD8 ratio in summer-type HP correlated with disease activity and improved upon environmental changes.

Conclusions:

  • The developed fluorescent microscopy method is simple, accurate, and effective for measuring BALF CD4/CD8 ratios.
  • This method is valuable for the diagnosis and monitoring of various diffuse pulmonary diseases.
  • BALF CD4/CD8 ratio serves as a useful biomarker for assessing disease status and therapeutic response in pulmonary conditions.

Related Concept Videos